DK495089D0 - Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler - Google Patents
Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidlerInfo
- Publication number
- DK495089D0 DK495089D0 DK495089A DK495089A DK495089D0 DK 495089 D0 DK495089 D0 DK 495089D0 DK 495089 A DK495089 A DK 495089A DK 495089 A DK495089 A DK 495089A DK 495089 D0 DK495089 D0 DK 495089D0
- Authority
- DK
- Denmark
- Prior art keywords
- thromboxan
- preparation
- receptor antagonists
- medicinal products
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/254,899 US4839384A (en) | 1988-10-07 | 1988-10-07 | Method of inhibiting onset of or treating migraine headache using a thromboxane A2 receptor antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK495089D0 true DK495089D0 (da) | 1989-10-06 |
| DK495089A DK495089A (da) | 1990-04-08 |
Family
ID=22966012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK495089A DK495089A (da) | 1988-10-07 | 1989-10-06 | Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4839384A (da) |
| EP (1) | EP0362587A3 (da) |
| JP (1) | JPH02145518A (da) |
| AU (1) | AU626917B2 (da) |
| CA (1) | CA1336686C (da) |
| DK (1) | DK495089A (da) |
| HU (1) | HU206826B (da) |
| NZ (1) | NZ230914A (da) |
| PT (1) | PT91923A (da) |
| ZA (1) | ZA897517B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4975279A (en) * | 1989-10-10 | 1990-12-04 | E. R. Squibb & Sons, Inc. | Method of improving post-ischemic myocardial function using a thromboxane A2 antagonist in combination with a thrombolytic agent and combination |
| ZA911453B (en) * | 1990-03-19 | 1991-11-27 | Squibb & Sons Inc | Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation |
| GB9720270D0 (en) * | 1997-09-25 | 1997-11-26 | Pharmagene Lab Limited | Medicaments for the treatment of migraine |
| US20030158240A1 (en) * | 1998-09-25 | 2003-08-21 | Pharmagene Laboratories Limited | Methods for the treatment of primary headache disorders using prostanoid EP4 receptor antagonists, and assays for agents for such treatment |
| WO2001089519A1 (en) * | 2000-05-22 | 2001-11-29 | Nitromed, Inc. | Thromboxane inhibitors, compositions and methods of use related applications |
| US6284790B1 (en) | 2000-06-15 | 2001-09-04 | Sachin Gupte | Methods of potentiating organic nitrates having vasodilating activity and formulations for the same |
| DK3142655T3 (da) | 2014-05-16 | 2021-02-01 | Cumberland Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til behandling af hjertefibrose med ifetroban |
| CN107708692A (zh) | 2015-06-30 | 2018-02-16 | 坎伯兰医药品股份有限公司 | Aerd/哮喘中的血栓烷受体拮抗剂 |
| WO2017197107A1 (en) | 2016-05-11 | 2017-11-16 | Cumberland Pharmaceuticals, Inc. | Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists |
| TW201924719A (zh) | 2017-11-29 | 2019-07-01 | 美國凡德貝爾大學 | 抑制腫瘤移轉的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4537981A (en) * | 1981-11-09 | 1985-08-27 | E. R. Squibb & Sons, Inc. | 7-Oxabicycloheptane and 7-oxabicycloheptene compounds |
| GB2146473B (en) * | 1983-09-10 | 1987-03-11 | Standard Telephones Cables Ltd | Addressing liquid crystal displays |
| GB8511895D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Heterocyclic compounds |
| GB8511894D0 (en) * | 1985-05-10 | 1985-06-19 | Ici Plc | Phenol derivatives |
| US4663336A (en) * | 1985-07-01 | 1987-05-05 | E. R. Squibb & Sons, Inc. | 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease |
| WO1987002983A1 (en) * | 1985-11-12 | 1987-05-21 | Imperial Chemical Industries Plc | Amide derivatives |
-
1988
- 1988-10-07 US US07/254,899 patent/US4839384A/en not_active Expired - Lifetime
-
1989
- 1989-09-08 CA CA000610819A patent/CA1336686C/en not_active Expired - Fee Related
- 1989-09-14 EP EP19890116995 patent/EP0362587A3/en not_active Withdrawn
- 1989-10-03 AU AU42540/89A patent/AU626917B2/en not_active Ceased
- 1989-10-03 ZA ZA897517A patent/ZA897517B/xx unknown
- 1989-10-05 NZ NZ230914A patent/NZ230914A/en unknown
- 1989-10-06 JP JP1262831A patent/JPH02145518A/ja active Pending
- 1989-10-06 DK DK495089A patent/DK495089A/da not_active Application Discontinuation
- 1989-10-06 HU HU895248A patent/HU206826B/hu not_active IP Right Cessation
- 1989-10-06 PT PT91923A patent/PT91923A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK495089A (da) | 1990-04-08 |
| HU206826B (en) | 1993-01-28 |
| ZA897517B (en) | 1990-06-27 |
| AU4254089A (en) | 1990-04-12 |
| NZ230914A (en) | 1997-06-24 |
| PT91923A (pt) | 1990-04-30 |
| JPH02145518A (ja) | 1990-06-05 |
| US4839384A (en) | 1989-06-13 |
| EP0362587A3 (en) | 1991-07-24 |
| EP0362587A2 (en) | 1990-04-11 |
| CA1336686C (en) | 1995-08-15 |
| AU626917B2 (en) | 1992-08-13 |
| HU895248D0 (en) | 1990-01-28 |
| HUT58517A (en) | 1992-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK362189A (da) | Farmaceutisk praeparat til intravenoes indgift | |
| DK156376C (da) | Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug | |
| DK180790D0 (da) | Fremstilling af farmaceutisk praeparat | |
| DK299089D0 (da) | Anvendelse af prostaglandiner til fremstilling af laegemidler | |
| DK418489A (da) | Anvendelse af purinderivater til fremstilling af antivirale farmaceutika | |
| DK645788A (da) | Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat | |
| DK495089A (da) | Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler | |
| DK603988D0 (da) | Farmaceutisk praeparat | |
| DK689188D0 (da) | Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat | |
| DK256290A (da) | Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling | |
| DK95489D0 (da) | Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel | |
| DK30489A (da) | Fremgangsmaade til fremstilling af pyranderivater | |
| DK473088D0 (da) | Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel | |
| DK336489A (da) | Farmaceutisk praeparat | |
| DK473288A (da) | Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel | |
| DK115291D0 (da) | Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater | |
| DK560989D0 (da) | Anvendelse af ethylendiamintetraeddikesyre til fremstilling af laegemidler | |
| DK318689A (da) | Anvendelse af lactamimider til fremstilling af calcium-antagonister | |
| DK143889A (da) | Fremgangsmaade til fremstilling af naphthalenderivater | |
| DK173789D0 (da) | Anvendelsen af tp-receptorantagonister til at modificere virkningen af myofibroblaster | |
| DK37589A (da) | Farmaceutisk praeparat for 4-aroylimidazol-2-oner | |
| DK293589D0 (da) | Fremgangsmaade til fremstiling af lactolderivater | |
| DK171089A (da) | Anvendelse af tetrazolderivater til fremstilling af laegemidler | |
| DK302887A (da) | Anvendelse af tumornecrosefaktor-alfa til fremstilling af antiinfektivt laegemiddel | |
| DK599689D0 (da) | Fremgangsmaade til fremstilling af naphthalenderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |